To treat the first patient who received the personalized tumor vaccine Neonkovak, 10 injections were required, after whom the scientific director of the Research Center for Epidemiology and Microbiology was named. N. P. Gamaliya, RAS Academician Alexander Gintsburg.
"We determine the level of protective cells that appear as a result of using the vaccine. And when the level reaches, it reaches the level, here, naturally, further treatment stops, and the doctors continue to monitor how the treatment process for this cancer patient develops. For the first time, 10 injections were required."
Earlier, Gintsburg reported that the first patient who received the Russian vaccine had no metastases, and after four months of observation, no tumors were detected. The vaccine was given on April 1 to a 60-year-old resident of the Kursk region.
In order not to miss our exclusivity: website | Max | telegram.